Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Weight Gain × Metformin × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 5 Weight Gain 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Obesity 1 Diabetes, Gestational 1 Diabetes Mellitus 1 Breast Neoplasms 1

Interventions

empagliflozin 1 Tablets 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06140108 2025-05-14

Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

SINA Health Education and Welfare Trust

Phase 2/3 Completed

Polycystic Ovary Syndrome, Weight Gain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡